Immunocore Holdings (IMCR) Total Current Liabilities: 2022-2025
Historic Total Current Liabilities for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $170.4 million.
- Immunocore Holdings' Total Current Liabilities fell 36.02% to $170.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.4 million, marking a year-over-year decrease of 36.02%. This contributed to the annual value of $212.2 million for FY2024, which is 52.63% up from last year.
- As of Q3 2025, Immunocore Holdings' Total Current Liabilities stood at $170.4 million, which was up 0.16% from $170.1 million recorded in Q2 2025.
- In the past 5 years, Immunocore Holdings' Total Current Liabilities ranged from a high of $266.2 million in Q3 2024 and a low of $100.8 million during Q4 2022.
- For the 3-year period, Immunocore Holdings' Total Current Liabilities averaged around $180.9 million, with its median value being $170.2 million (2025).
- As far as peak fluctuations go, Immunocore Holdings' Total Current Liabilities surged by 52.63% in 2024, and later crashed by 36.02% in 2025.
- Over the past 4 years, Immunocore Holdings' Total Current Liabilities (Quarterly) stood at $100.8 million in 2022, then soared by 37.87% to $139.0 million in 2023, then spiked by 52.63% to $212.2 million in 2024, then slumped by 36.02% to $170.4 million in 2025.
- Its Total Current Liabilities was $170.4 million in Q3 2025, compared to $170.1 million in Q2 2025 and $149.2 million in Q1 2025.